News
Some 311 operating companies went public in IPOs with an initial stock price of $5 or more in 2021, according to data from ...
6h
Barchart on MSNShould You Buy JBS Stock After the Meat Giant’s IPO?The initial public offerings (IPO) keep on coming in 2025. From trading platform eToro (TORO) to stablecoin issuer Circle (CRCL) and health tech platform Omada (OMDA), it seems that investors are ...
Shares of Sarepta Therapeutics, Inc. SRPT fell sharply in today's pre-market trading after the company suspended ELEVIDYS ...
The company reported second-quarter revenue of $5.87 billion, beating analyst estimates of $5.79 billion, according to ...
Today, the AMA tackles AI. Plus: takeaways from the Omada IPO.
Health-care companies were more or less flat as traders sought out defensive sectors in light of doubts about a trade deal. Pennsylvania lawmakers took a step toward enacting restrictions on ...
5d
Barchart on MSNShould You Buy Omada Health Stock After the OMDA IPO?Despite concerns about valuations, the U.S. tech sector continues to remain in high demand. This is evidenced by a spate of ...
In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding ...
Newly public Omada Health says it won't turn patient care over to AI as the tech consumes investor interest.
Health-care companies rose amid sales growth optimism. Drug-store chain CVS Health said it has seen complaints of strong push back from patients on its pharmacy-benefit manager's move to favor Novo ...
Hims & Hers (NYSE: HIMS) stock, a prominent player in the booming telehealth sector, has undeniably captured significant investor attention recently. Perhaps you, like many others, have been caught up ...
Aribio Co. Ltd. signed a $600 million license deal with Acino International AG, an Arcera Life Sciences subsidiary, granting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results